Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Clinical Utility of Molecular Biomarkers in Cervical Squamous Intraepithelial Lesions in a Young Adult Population.

Spiryda LB, Whitaker KM, Messersmith A, Banister CE, Creek KE, Pirisi-Creek LA.

J Low Genit Tract Dis. 2016 Jan;20(1):26-30. doi: 10.1097/LGT.0000000000000163.

2.

HPV infection and cervical neoplasia: associated risk factors.

Ribeiro AA, Costa MC, Alves RR, Villa LL, Saddi VA, Carneiro MA, Zeferino LC, Rabelo-Santos SH.

Infect Agent Cancer. 2015 May 26;10:16. doi: 10.1186/s13027-015-0011-3. eCollection 2015.

3.

HPV mRNA is more specific than HPV DNA in triage of women with minor cervical lesions.

Sørbye SW, Fismen S, Gutteberg TJ, Mortensen ES, Skjeldestad FE.

PLoS One. 2014 Nov 18;9(11):e112934. doi: 10.1371/journal.pone.0112934. eCollection 2014.

4.

Condom and oral contraceptive use and risk of cervical intraepithelial neoplasia in Australian women.

Chih HJ, Lee AH, Colville L, Xu D, Binns CW.

J Gynecol Oncol. 2014 Jul;25(3):183-7. doi: 10.3802/jgo.2014.25.3.183. Epub 2014 Jul 3.

5.

HPV prevalence at enrollment and baseline results from the Carolina Women's Care Study, a longitudinal study of HPV persistence in women of college age.

Banister CE, Messersmith AR, Chakraborty H, Wang Y, Spiryda LB, Glover SH, Pirisi L, Creek KE.

Int J Womens Health. 2013 Jul 2;5:379-88. doi: 10.2147/IJWH.S45590. Print 2013.

6.

Compliance with cervical cancer screening and human papillomavirus testing guidelines among insured young women.

Hirth JM, Tan A, Wilkinson GS, Berenson AB.

Am J Obstet Gynecol. 2013 Sep;209(3):200.e1-7. doi: 10.1016/j.ajog.2013.05.058. Epub 2013 May 30.

7.

Updating the natural history of human papillomavirus and anogenital cancers.

Moscicki AB, Schiffman M, Burchell A, Albero G, Giuliano AR, Goodman MT, Kjaer SK, Palefsky J.

Vaccine. 2012 Nov 20;30 Suppl 5:F24-33. doi: 10.1016/j.vaccine.2012.05.089. Review.

8.

The role of co-factors in the progression from human papillomavirus infection to cervical cancer.

Luhn P, Walker J, Schiffman M, Zuna RE, Dunn ST, Gold MA, Smith K, Mathews C, Allen RA, Zhang R, Wang S, Wentzensen N.

Gynecol Oncol. 2013 Feb;128(2):265-70. doi: 10.1016/j.ygyno.2012.11.003. Epub 2012 Nov 10.

9.
10.

Increasing rates of cervical cancer in young women in England: an analysis of national data 1982-2006.

Foley G, Alston R, Geraci M, Brabin L, Kitchener H, Birch J.

Br J Cancer. 2011 Jun 28;105(1):177-84. doi: 10.1038/bjc.2011.196. Epub 2011 Jun 7.

11.

Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women.

Moscicki AB, Ma Y, Wibbelsman C, Darragh TM, Powers A, Farhat S, Shiboski S.

Obstet Gynecol. 2010 Dec;116(6):1373-80. doi: 10.1097/AOG.0b013e3181fe777f.

12.

Human papillomavirus disease and vaccines in adolescents.

Moscicki AB.

Adolesc Med State Art Rev. 2010 Aug;21(2):347-63, x-xi. Review.

13.

Lessons from practice: risk of CIN 3 or cancer associated with an LSIL or HPV-positive ASC-US screening result in women aged 21 to 24.

Moore G, Fetterman B, Cox JT, Poitras N, Lorey T, Kinney W, Castle PE.

J Low Genit Tract Dis. 2010 Apr;14(2):97-102. doi: 10.1097/LGT.0b013e3181b8b024.

Supplemental Content

Support Center